All NewsFDA BriefsOncology IconsSpecial ReportsVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPrecision Medicine
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CME/CE
Case-Based Roundtable SeriesClinical TrialsPartnersPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
eNewsletterPrint Subscription
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2-Positive Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CME/CE
Advertisement

Christopher R. Flowers, MD

home / authors / christopher-r-flowers-md

Articles

Advertisement

Pursuing Optimal Therapy Remains a Challenge in Indolent B-Cell Lymphoma

Pursuing Optimal Therapy Remains a Challenge in Indolent B-Cell Lymphoma

October 25th 2021

A significant proportion of patients worldwide live disease-free for a decade or longer following first-line therapy, with various approaches suggesting that there may be pathways to develop approaches for a cure for at least a subset of patients


Reviewing Current Therapies in Relapsed DLBCL and the L-MIND Trial

Reviewing Current Therapies in Relapsed DLBCL and the L-MIND Trial

August 24th 2021

Christopher R. Flowers, MD, discusses the current therapies used for patients with relapsed/refractory diffuse large B-cell lymphoma and goes into specifics of the L-MIND trial after the long-term follow-up.


Follicular Lymphoma Management: Future Directions

Follicular Lymphoma Management: Future Directions

June 19th 2020

Idelalisib for Relapsed/Refractory FL

Idelalisib for Relapsed/Refractory FL

June 19th 2020

PI3K Inhibitors for Relapsed/Refractory FL

PI3K Inhibitors for Relapsed/Refractory FL

June 19th 2020

Treatment Options for Relapsed Follicular Lymphoma

Treatment Options for Relapsed Follicular Lymphoma

June 19th 2020
Advertisement

Maintenance Therapy for Patients With Follicular Lymphoma

Maintenance Therapy for Patients With Follicular Lymphoma

June 19th 2020

Frontline Treatment for Newly Diagnosed Follicular Lymphoma

Frontline Treatment for Newly Diagnosed Follicular Lymphoma

June 19th 2020

Predicting Outcomes for a Patient With Follicular Lymphoma

Predicting Outcomes for a Patient With Follicular Lymphoma

June 19th 2020

Case Overview: A 77-Year-Old Man With Follicular Lymphoma

Case Overview: A 77-Year-Old Man With Follicular Lymphoma

June 19th 2020

A 77-Year-Old Man With Follicular Lymphoma

A 77-Year-Old Man With Follicular Lymphoma

June 19th 2020

Christopher Flowers, MD, describes the management of an elderly patient with relapsed follicular lymphoma using newer novel therapy.

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.